TISSUE-SPECIFIC TREATMENT, DIAGNOSTIC METHODS, AND COMPOSITIONS USING REPLICATION-DEFICIENT VECTORS Read more about TISSUE-SPECIFIC TREATMENT, DIAGNOSTIC METHODS, AND COMPOSITIONS USING REPLICATION-DEFICIENT VECTORS US Application 08/849,120Filed on 1997-05-28
Nucleic Acids Encoding Antiviral Proteins and Peptides Fused to Effector Proteins Read more about Nucleic Acids Encoding Antiviral Proteins and Peptides Fused to Effector Proteins US Patent 5,962,668Filed on 1997-11-13
Methods Of Using Cyanovirins Read more about Methods Of Using Cyanovirins US Patent 6,015,876Filed on 1997-11-13
Methods Of Obtaining Antiviral Proteins And Antiviral Peptides From Nostoc Ellipsosporum Read more about Methods Of Obtaining Antiviral Proteins And Antiviral Peptides From Nostoc Ellipsosporum US Patent 5,962,653Filed on 1997-11-13
AUTOTAXIN: MOTILITY STIMULATING PROTEIN USEFUL IN CANCER DIAGNOSIS AND THERAPY Read more about AUTOTAXIN: MOTILITY STIMULATING PROTEIN USEFUL IN CANCER DIAGNOSIS AND THERAPY US Patent 6,084,069Filed on 1997-11-24
SELECTIVE PREVENTION OF ORGAN INJURY IN SEPSIS AND SHOCK USING SELECTION RELEASE OF NITRIC OXIDE IN VULNERABLE ORGANS Read more about SELECTIVE PREVENTION OF ORGAN INJURY IN SEPSIS AND SHOCK USING SELECTION RELEASE OF NITRIC OXIDE IN VULNERABLE ORGANS US Patent 5,814,656Filed on 1997-10-02
Immunotoxin Containing a Disulfide-Stablized Antibody Fragment Joined to a Pseudomonas Exotoxin That Does Not Require Proteolytic Activation Read more about Immunotoxin Containing a Disulfide-Stablized Antibody Fragment Joined to a Pseudomonas Exotoxin That Does Not Require Proteolytic Activation US Patent 5,980,895Filed on 1997-08-21
RECOMBINANT RIBONUCLEASE PROTEINS Read more about RECOMBINANT RIBONUCLEASE PROTEINS US Patent 6,045,793Filed on 1998-02-19
Method of Treating Inflammation with Antibodies to Neutrophil Chemotactic Factor (As Amended). Read more about Method of Treating Inflammation with Antibodies to Neutrophil Chemotactic Factor (As Amended). US Patent 5,925,352Filed on 1997-09-23
8-CI Camp as Anti-Cancer Drug Read more about 8-CI Camp as Anti-Cancer Drug US Patent 5,902,794Filed on 1997-09-22